Its a good and bad thing. It allows us to buy more along the way, knowing how undervalued we are. End of the day the world cant ignore us when we publish good results, and we will rip away the market from our competitors... If we list in the US toward the end of the year it will be the best chance we have of exploding when the time comes!
Sanofi Signs Benitec's closest competitor Voyager for $845M, page-7
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)